Published in Mucosal Immunol on April 04, 2012
Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol (2013) 1.00
Neuroimmune semaphorin 4A as a drug and drug target for asthma. Int Immunopharmacol (2013) 0.83
Cytokines in chronic respiratory diseases. F1000 Biol Rep (2013) 0.81
Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation. Mol Immunol (2013) 0.77
Transmembrane semaphorins: Multimodal signaling cues in development and cancer. Cell Adh Migr (2016) 0.76
The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). PLoS One (2015) 0.76
Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A. Oncotarget (2016) 0.75
Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res Ther (2015) 0.75
The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems. Cell Adh Migr (2016) 0.75
Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
The asthma epidemic. N Engl J Med (2006) 8.60
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med (2010) 6.90
Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol (2004) 4.72
In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med (2005) 4.34
Asthma: an epidemic of dysregulated immunity. Nat Immunol (2002) 4.00
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol (2001) 3.91
The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell (1993) 3.48
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med (1998) 3.22
A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol (1998) 3.19
Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med (2009) 2.72
Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med (2008) 2.25
IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol (2008) 2.17
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature (2002) 2.04
The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92
Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86
T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med (1999) 1.85
IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol (2002) 1.81
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir J (2008) 1.79
Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest (2010) 1.73
The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet (2010) 1.71
T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol (2006) 1.51
IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol (2009) 1.48
Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity (2005) 1.39
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J (2007) 1.28
Asthma: is it due to an abnormal airway smooth muscle cell? Am J Respir Crit Care Med (2006) 1.27
PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity (2008) 1.27
Immune semaphorins: a new area of semaphorin research. J Cell Sci (2003) 1.25
Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol (2010) 1.23
Severe retinal degeneration associated with disruption of semaphorin 4A. Invest Ophthalmol Vis Sci (2004) 1.08
Targeting airway inflammation: novel therapies for the treatment of asthma. Curr Med Chem (2006) 1.04
Biology and function of neuroimmune semaphorins 4A and 4D. Immunol Res (2011) 1.03
Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13. J Immunol (2007) 1.00
Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest (1999) 0.95
An adoptive transfer model of allergic lung inflammation in mice is mediated by CD4+CD62LlowCD25+ T cells. J Immunol (1999) 0.95
New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma. Curr Opin Allergy Clin Immunol (2011) 0.95
STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease. J Immunol (2011) 0.94
Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats. Immunology (1997) 0.92
Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol (2011) 0.90
Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation. J Allergy Clin Immunol (2009) 0.90
Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. Clin Immunol (2009) 0.89
HLA-DQ6 and HLA-DQ8 transgenic mice respond to ragweed allergens and recognize a distinct set of epitopes on short and giant ragweed group 5 antigens. J Immunol (1998) 0.85
Immunological tolerance to inhaled antigen. Am J Respir Crit Care Med (2000) 0.84
Novel strategies for the treatment of asthma. Recent Pat Inflamm Allergy Drug Discov (2007) 0.84
Semaphorin 4A induces growth cone collapse of hippocampal neurons in a Rho/Rho-kinase-dependent manner. Int J Mol Med (2005) 0.81
Involvement of Sema4A in the progression of experimental autoimmune myocarditis. FEBS Lett (2008) 0.81
Asthma therapy: how far have we come, why did we fail and where should we go next? Eur Respir J (2009) 0.78
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (1996) 10.67
Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res (1997) 6.37
The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol (1999) 6.19
The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity (1994) 6.18
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A (1987) 5.68
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
An integrated computational pipeline and database to support whole-genome sequence annotation. Genome Biol (2002) 5.24
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 4.63
Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A (1994) 4.25
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem (2001) 3.69
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev (1990) 3.50
Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell (1986) 3.34
Private health care in developing countries. BMJ (2001) 2.89
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut (2003) 2.74
Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science (1999) 2.61
Mouse liver cell culture. I. Hepatocyte isolation. In Vitro (1981) 2.50
Preventing child abuse and neglect with a program of nurse home visitation: the limiting effects of domestic violence. JAMA (2000) 2.50
Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci (2010) 2.40
c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35
Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J Virol (1991) 2.28
Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med (1986) 2.25
CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (1995) 2.23
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity (2000) 2.16
Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell (1988) 2.09
Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity (1996) 2.05
Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature (1987) 2.04
The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity (2000) 1.96
Genetic control of diabetes progression. Immunity (1997) 1.95
Prevalence of psychiatric disorders among persons convicted of driving while impaired. Arch Gen Psychiatry (2001) 1.93
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol (1988) 1.92
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood (2000) 1.90
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology (2007) 1.90
Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am J Hum Genet (1998) 1.87
Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res (2001) 1.85
Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol (1995) 1.85
Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices (2009) 1.81
Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol (2001) 1.80
A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes. J Immunol (1987) 1.79
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol (2010) 1.78
Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest (1997) 1.73
New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol (2008) 1.73
Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol Cell Biol (2000) 1.73
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A (1993) 1.71
CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J Exp Med (1996) 1.62
A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood. Neurology (1989) 1.62
Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature (1990) 1.61
The representation of pleasant touch in the brain and its relationship with taste and olfactory areas. Neuroreport (1999) 1.61
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem (2001) 1.58
B cell growth and differentiation factors and mechanism of B cell activation. Immunol Rev (1984) 1.57
Impairment of T cell development in deltaEF1 mutant mice. J Exp Med (1997) 1.56
The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report. Cancer Clin Trials (1980) 1.54
Antidepressant analgesia in rheumatoid arthritis. J Rheumatol (1988) 1.53
Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders. J Child Neurol (1989) 1.53
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem (1988) 1.49
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Bacterial Content of Frosted Hamburg Steak. Am J Public Health Nations Health (1933) 1.45
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. Brain (1987) 1.44
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol (1993) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J Immunol (2000) 1.41
Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J Invest Dermatol (1998) 1.40
The interaction of antibiotics with synthetic steroids in the rat [proceedings]. Br J Pharmacol (1978) 1.40
T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med (1991) 1.40
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
Identifying priority patients for coronary angiography. Int J Clin Pract (2001) 1.39
Monoclonal anti-Fc epsilon receptor antibodies with different specificities and studies on the expression of Fc epsilon receptors on human B and T cells. J Immunol (1986) 1.39
Learning to help. Nurs Times (1990) 1.38
Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A. Br J Rheumatol (1994) 1.37
Structural characterization of Dictyostelium discoideum prespore-specific gene D19 and of its product, cell surface glycoprotein PsA. Mol Cell Biol (1988) 1.37
Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J Biochem (1984) 1.35
Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood (2001) 1.34
Impact of follow up letters on non-attenders for breast screening: a general practice based study. J Med Screen (1997) 1.33
Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol (1998) 1.31
IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J (1992) 1.31
Mouse liver cell culture. II. Primary culture. In Vitro (1981) 1.31
THE PREVENTION, SYMPTOMS, AND TREATMENT OF TETRYL DERMATITIS. Br Med J (1916) 1.31
Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc Natl Acad Sci U S A (1993) 1.30
Functional V region formation during in vitro culture of a murine immature B precursor cell line. Nature (1983) 1.30
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women. HIV Clin Trials (2001) 1.30
Effect of B cell stimulatory factor-1 (interleukin 4) on Fc epsilon and Fc gamma receptor expression on murine B lymphocytes and B cell lines. J Immunol (1987) 1.29
The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol (2001) 1.28
Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun (1998) 1.27
Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature (1976) 1.26
Evidence that the mechanism of gene exchange in Trypanosoma brucei involves meiosis and syngamy. Parasitology (1990) 1.26
T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell Immunol (1996) 1.23
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials (2008) 1.22
Cytotoxicity of adriamycin on aerobic and hypoxic chinese hamster V79 cells in vitro. Br J Cancer (1980) 1.22
Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care (2009) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Management of attempted suicide in Oxford. Br Med J (1979) 1.19